Computational Pharmacology & Toxicology Laboratory, Discipline of Pharmacology, School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.
Chem Res Toxicol. 2023 Aug 21;36(8):1227-1237. doi: 10.1021/acs.chemrestox.2c00372. Epub 2023 Jul 21.
The prediction of Ames mutagenicity continues to be a concern in both regulatory and pharmacological toxicology. Traditional quantitative structure-activity relationship (QSAR) models of mutagenicity make predictions based on molecular descriptors calculated on a chemical data set used in their training. However, it is known that molecules such as aromatic amines can be non-mutagenic themselves but metabolically activated by S9 rodent liver enzyme in Ames tests forming molecules such as iminoquinones or amine substituents that better stabilize mutagenic nitrenium ions in known pathways of mutagenicity. Modern modeling methods can implicitly model these metabolites through consideration of the structural elements relevant to their formation but do not include explicit modeling of these metabolites' potential activity. These metabolites do not have a known individual mutagenicity label and, in their current state, cannot be fitted into a traditional QSAR model. Multiple instance learning (MIL) however can be applied to a group of metabolites and their parent under a single mutagenicity label. Here we trained MIL models on Ames data, first with an aromatic amines data set ( = 457), a class known to require metabolic activation, and subsequently on a larger data set ( = 6505) incorporating multiple molecular species. MIL was shown to be able to predict Ames mutagenicity with performance in line with previously established models (balanced accuracy = 0.778), suggesting its potential utility in Ames prediction applications. Furthermore, the MIL model predicted well on identified hard-to-predict molecule groups relative to the models in which these molecule groups were identified. These results are presumably due to the increased consideration of the metabolic contribution to the mutagenic outcome. Further exploration of MIL as a supplement to existing models could aid in the prediction of chemicals where implicit modeling of metabolites cannot fully grasp their characteristics. This paper demonstrates the potential of an MIL approach to modeling Ames tests with S9 and is particularly relevant to metabolically activated xenobiotic mutagens.
Ames 致突变性的预测在监管和药理学毒理学中仍然是一个关注点。传统的致突变性定量构效关系(QSAR)模型基于在其训练中使用的化学数据集上计算的分子描述符进行预测。然而,众所周知,芳香胺等分子本身可能是非致突变的,但在 Ames 测试中,通过 S9 啮齿动物肝酶代谢激活,形成亚硝酮或胺取代基等分子,更好地稳定已知致突变途径中的致突变亚硝鎓离子。现代建模方法可以通过考虑与其形成相关的结构元素来隐含地模拟这些代谢物,但不包括这些代谢物潜在活性的显式建模。这些代谢物没有已知的个体致突变性标签,并且在其当前状态下,无法拟合到传统的 QSAR 模型中。多实例学习 (MIL) 可以应用于一组代谢物及其母体,采用单一的致突变性标签。在这里,我们使用 Ames 数据对 MIL 模型进行了训练,首先使用芳香胺数据集( = 457)进行训练,这是一类已知需要代谢激活的数据集,随后使用包含多种分子的更大数据集( = 6505)进行训练。结果表明,MIL 能够以与先前建立的模型相当的性能(平衡准确性 = 0.778)预测 Ames 致突变性,表明其在 Ames 预测应用中的潜在效用。此外,与识别出的难以预测的分子群体的模型相比,MIL 模型对这些分子群体的预测效果更好。这些结果可能归因于对代谢物致突变结果的贡献的增加考虑。进一步探索 MIL 作为现有模型的补充,可能有助于预测那些不能完全掌握其特征的代谢物的化学物质。本文证明了 MIL 方法在 S9 中模拟 Ames 测试的潜力,特别是与代谢激活的外源性诱变剂相关。